Treatment of CFS and Fibromyalgia With HRG 80 Red Ginseng
NCT ID: NCT04599348
Last Updated: 2020-10-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
70 participants
INTERVENTIONAL
2020-10-14
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Fibromyalgia and CFS With Ribose, Ashwagandha, Rhodiola, Licorice, Schisandra and Green Tea Extract
NCT04598243
Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease
NCT03983408
American Ginseng Treatment for Multiple Sclerosis Related Fatigue
NCT00754832
Efficacy Study of Korean Red Ginseng to Treat Depression
NCT01496248
Ginseng HRG80 in Stress and Fatigue
NCT03947554
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study is an open pilot study to explore whether this treatment would be helpful for improving clinical function and symptomatology in chronic fatigue syndrome and fibromyalgia. Current clinical experience is suggesting that it may be.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Ginseng treatment
People with CFS or Fibromyalgia will receive HRG 80 Red GInseng
HRG 80 Red Ginseng
A unique form of ginseng with the high level of active ginseng components similar to those found in the wild ginseng used in earlier studies.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HRG 80 Red Ginseng
A unique form of ginseng with the high level of active ginseng components similar to those found in the wild ginseng used in earlier studies.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. live in the United States 3 - be over 18 years of age
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Practitioners Alliance Network
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jacob Teitelbaum
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacob Teitelbaum
Role: PRINCIPAL_INVESTIGATOR
FFTF LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kona Research Center
Kailua, Hawaii, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PAN-HRG80-2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.